Sheng-Bin Peng

Title: The Innovative Contributions of Sheng-Bin Peng

Introduction

Sheng-Bin Peng is a notable inventor based in Carmel, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of cancer treatments. With a total of 9 patents to his name, his work has had a profound impact on medical science.

Latest Patents

Among his latest patents are the KRas G12C inhibitors. The first patent provides compounds of a specific formula, where R, R, R, R, R, A, B, and Y are defined, along with pharmaceutically acceptable salts. These compounds and their salts are intended for use in treating patients with cancer. The second patent also focuses on KRas G12C inhibitors, detailing compounds of Formula I, where R1, R2, and m are specified, along with their pharmaceutically acceptable salts and methods for treating cancer.

Career Highlights

Sheng-Bin Peng has worked with prominent companies in the pharmaceutical industry, including Eli Lilly and Company and Deciphera Pharmaceuticals, LLC. His experience in these organizations has allowed him to contribute to groundbreaking research and development in cancer therapies.

Collaborations

Throughout his career, Sheng-Bin Peng has collaborated with esteemed colleagues, including Daniel L. Flynn and Michael D. Kaufman. These partnerships have further enhanced his innovative work in the field.

Conclusion

Sheng-Bin Peng's contributions to cancer treatment through his patents and collaborations highlight his importance as an inventor in the pharmaceutical industry. His ongoing work continues to inspire advancements in medical science.